"Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report.
Fibrolamellar (FL) hepatocellular carcinoma (HCC) is a distinctive form of primary HCC that occurs principally in children and young adults. Although liver transplantation is not contraindicated for FL-HCC, noncirrhotic patients with large HCC tumors (including FL-HCCs) are not prioritized. Although hepatic resection is considered to be the primary treatment for FL-HCC, living donor liver transplantation is evolving into a potentially better alternative. Herein we have reported successful "preemptive" living donor liver transplantation for presumed recurrence of FL-HCC after an extended right hepatectomy with resection and synthetic graft replacement of the inferior vena cava.
Fouzas
I
I
Department of General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany.
Sotiropoulos
G C
GC
Molmenti
E P
EP
Beckebaum
S
S
Schmitz
K J
KJ
Broelsch
C E
CE
Lang
H
H
Malagó
M
M
D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D005165:Factor V / Q000235:genetics; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D019520:Living Donors; D009154:Mutation; D011859:Radiography; D012449:Safety
C095381:factor V Leiden; D005165:Factor V